1.

Which of the following is the first non-factor prophylactic bypassing agent that was recently approved for haemophilia A patients with and without inhibitors?

A. Tocilizumab
B. Itolizumab
C. Hemilizumab
D. Emicizumab
Answer» E.


Discussion

No Comment Found